발행물

전체 논문

255

41

A novel DDR1 Inhibitor Enhances the Anticancer Activity of Gemcitabine in Pancreatic Cancer
Ko, S., Jung, K.-H., Yoon, Y.-C., Han, B. S., Park, M. S., Lee, Y. J., Kim, S. E., Cho, Y. J., Ryu, J. K., Kim, K., Kim, T. Y., Hong, S.*, Lee, S. H.*, Hong, S.-S.*
Am. J. Cancer Res., 2022

42

N-Functionalized Pyridinium salts: A New Chapter for Site-Selective Pyridine C–H Functionalization via Radical-Based Processes under Visible Light Irradiation
Kim, M., Koo, Y., Hong, S.*
Acc. Chem. Res., 2022

43

Two-Track Virtual Screening Approach to Identify the Dual Inhibitors of Wild Type and C481S Mutant of Bruton’s Tyrosine Kinase
Kim, T., Kim, K., Park, I., Hong, S.*, Park, H.*
J. Chem. Inf. Model., 2022

44

Oxidatively Induced Reactivity in Rh(III)-Catalyzed 7-Azaindole Synthesis: Insights into the Role of the Silver Additive
Ryu, H., Pudasaini, B.: Cho, D., Hong, S.*, Baik, M.-H.*
Chem. Sci., 2022

45

Site-Selective Pyridylic C–H Functionalization by Photocatalytic Radical Cascades
Kim, M., You, E., Kim, J., Hong, S.*
Angew. Chem. Int. Ed., 2022

46

Nickel-Catalyzed Regio- and Enantioselective Hydroamination of Unactivated Alkenes Using Carbonyl Directing Groups
Lee, C., Kang, H. J., Seo, H., Hong, S.*
J. Am. Chem. Soc., 2022

47

Discovery of a novel NUAK1 inhibitor against pancreatic cancer through inhibition of PI3K/AKT pathway
Seo, M .S.: Jung, K. H., Kim, K., Lee, J. E., Han, B. S., Ko, S., Hong, S.*, Lee, S. H.*, Hong, S.-S.*
Biomed. Pharmacother., 2022

48

Enantioselective Functionalization at the C4 Position of Pyridinium Salts through NHC Catalysis
Choi, H., Mathi, G. R., Hong, S., Hong, S.*
Nature Commun., 2022

49

Regiodivergent Conversion of Alkenes to Branched or Linear Alkyl Pyridines
Kim. M., Shin, S., Koo, Y., Jung, S., Hong, S.*
Org. Lett., 2022

50

Visible-Light-Induced C4-Selective Functionalization of Pyridinium Salts with Cyclopropanols
Vellakkaran, M., Kim, T., Hong, S.*
Angew. Chem. Int. Ed., 2022